Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
As of: Sep 4, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Short-term Investments (2015 - 2026)

Argenx Se's (ARGX) quarterly Short-term Investments came in at $1.6 billion in Q2 2026, down 99.86% YoY from $1154.3 billion in Q2 2025, and up 68.6% on a QoQ basis from $949.0 million in Q4 2025.

Analysis

Argenx Se (ARGX) Short-term Investments (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has 12 years of Short-term Investments data on file, last reported at $1.6 billion in Q2 2026.

  • Quarterly Short-term Investments fell 99.86% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 99.86% YoY) and the FY2025 annual result came in at $2.4 billion, up 209.38% from the prior year.
  • Short-term Investments climbed to $1.6 billion in Q2 2026, from $949.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1154.3 billion in Q2 2025 to a low of -$1108.4 billion in Q2 2024.
  • A 5-year average of $6.1 billion and a median of $1.2 billion in 2022 frame the typical range for Short-term Investments.
  • Annual changes were most pronounced in 2024 — Short-term Investments plunged 125146.11% — and 2025, when it surged 204.14%.
  • Tracing ARGX's Short-term Investments over 5 years: stood at $1.4 billion in 2022, then declined by 18.74% to $1.1 billion in 2023, then jumped by 66.13% to $1.9 billion in 2024, then sank by 49.49% to $949.0 million in 2025, then surged by 68.6% to $1.6 billion in 2026.
  • The last three Short-term Investments figures came in at $1.6 billion (Q2 2026), $949.0 million (Q4 2025), and $1154.3 billion (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Bn
Dec 31, 2025 949.00 Mn
Jun 30, 2025 1.15 Bn
Dec 31, 2024 1,878.89 Bn
Jun 30, 2024 -1,108.41 Bn
Dec 31, 2023 1.13 Bn
Jun 30, 2023 886.40 Mn
Dec 31, 2022 1,391.81 Bn
Jun 30, 2022 1.23 Bn
Dec 31, 2021 1,002.05 Bn
Jun 30, 2021 1.15 Bn
Mar 31, 2021 11.15 Mn
Dec 31, 2020 757.53 Bn
Sep 30, 2020 1.26 Mn
Jun 30, 2020 934,000.00
Dec 31, 2019 1.11 Bn
Jun 30, 2019 872.49 Mn
Dec 31, 2018 323.62 Mn
Jun 30, 2018 236.28 Mn
Dec 31, 2017 198.88 Mn